{
    "2020-06-17": [
        [
            {
                "time": "2023-10-01",
                "original_text": "医药生物行业周报：国内疫情存在反弹风险 核酸检测需求持续提升",
                "features": {
                    "keywords": [
                        "医药生物",
                        "疫情反弹",
                        "核酸检测",
                        "需求提升"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "贝达药业能否破题单品独大",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "单品独大",
                        "破题"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "龙头药企频繁“割肉”原因曝光！3大首仿、1类新药将冲击市场",
                "features": {
                    "keywords": [
                        "龙头药企",
                        "割肉",
                        "首仿",
                        "新药",
                        "市场冲击"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "贝达药业：根据市场情况合理定价贝伐珠单抗注射液",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "市场情况",
                        "合理定价",
                        "贝伐珠单抗"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "信达生物、海正&贝达、复宏汉霖 三款贝伐珠单抗同迎进展",
                "features": {
                    "keywords": [
                        "信达生物",
                        "海正",
                        "贝达",
                        "复宏汉霖",
                        "贝伐珠单抗",
                        "进展"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}